1 Min Read
March 31 (Reuters) - Endologix Inc-
* Endologix Inc announces enrollment of first patients in elevate IDE clinical study
* Continue to expect ovation alto could be available in U.S. In 2019 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.